Buonavoglia C, Cavalli A, Gravino E, Voigt V, Buonavoglia D, de Caprariis D
Istituto di Malattie Infettive e Parassitarie degli Animali, Facoltà di Medicina Veterinaria, Università Bari, Italia.
Zentralbl Veterinarmed B. 1994 Mar;41(1):3-8. doi: 10.1111/j.1439-0450.1994.tb00199.x.
The modified live canine parvovirus (CPV) vaccine was used to vaccinate intranasally twenty-five pups with maternal antibody. The vaccine was able to overcome the interference of maternal immunity in rates of 100%, 72.7% and 17.6% in pups with haemagglutination inhibition antibody titre of 40, 80 and 160 respectively.
使用改良的犬细小病毒（CPV）活疫苗对25只具有母源抗体的幼犬进行鼻内接种。对于血凝抑制抗体效价分别为40、80和160的幼犬，该疫苗克服母源免疫干扰的成功率分别为100%、72.7%和17.6%。
